Advertisement
Screener

PHIO PHARMACEUTICALS CORP. (PHIO) Form PRE 14A: Preliminary proxy statement

0.9 / 5 stars · 2/11 Roast Me

Add as a preferred source on Google

PHIO PHARMACEUTICALS CORP. Form PRE 14A: Preliminary proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-04-22: Form PRE 14A; Period of report 2024-06-17; Description PRELIMINARY PROXY STATEMENT; Document phio_pre14a.htm.
  • 2022-11-16: Form PRE 14A; Period of report 2023-01-04; Description PRELIMINARY PROXY STATEMENT; Document phio_pre14a.htm.
  • 2019-11-08: Form PRE 14A; Period of report 2019-12-31; Description PRELIMINARY NOTICE AND PROXY STATEMENT; Document phio_pre14a.htm.
  • 2019-08-12: Form PRE 14A; Period of report 2019-10-10; Description NOTICE AND PROXY STATEMENT; Document phio_pre14a.htm.
FiledFormPeriod of reportDescriptionDocument
2024-04-22PRE 14A2024-06-17PRELIMINARY PROXY STATEMENTphio_pre14a.htm
2022-11-16PRE 14A2023-01-04PRELIMINARY PROXY STATEMENTphio_pre14a.htm
2019-11-08PRE 14A2019-12-31PRELIMINARY NOTICE AND PROXY STATEMENTphio_pre14a.htm
2019-08-12PRE 14A2019-10-10NOTICE AND PROXY STATEMENTphio_pre14a.htm
2018-04-13PRE 14A2018-06-05PRE 14Ad563605dpre14a.htm
2017-04-12PRE 14A2017-06-06PRE 14Ad366780dpre14a.htm
2016-02-24PRE 14A2016-04-14PRE 14Ad291334dpre14a.htm
2014-04-04PRE 14A2014-06-02PRELIMINARY PROXY STATEMENTd703460dpre14a.htm

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
BIOVIE INC. (BIVI)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Moleculin Biotech, Inc. (MBRX)United States$0.011B
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33
Advertisement